Insider & Institutional Ownership
69.6% of shares of all “MED/DENTAL – SUPP” companies are held by institutional investors. 9.4% of shares of all “MED/DENTAL – SUPP” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Remedent and its rivals gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Net Income | Price/Earnings Ratio | |
Remedent | $990,000.00 | -$270,000.00 | -1.00 |
Remedent Competitors | $37.61 billion | $430.42 million | 20.09 |
Remedent’s rivals have higher revenue and earnings than Remedent. Remedent is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.
Profitability
Net Margins | Return on Equity | Return on Assets | |
Remedent | N/A | N/A | N/A |
Remedent Competitors | 2.88% | -3.91% | 7.65% |
Risk and Volatility
Remedent has a beta of -0.02, indicating that its share price is 102% less volatile than the S&P 500. Comparatively, Remedent’s rivals have a beta of 0.53, indicating that their average share price is 47% less volatile than the S&P 500.
Summary
Remedent rivals beat Remedent on 8 of the 9 factors compared.
Remedent Company Profile
Remedent, Inc. researches, designs, develops, manufactures, and distributes oral care and cosmetic dentistry products in the United States and internationally. It primarily provides professional veneers and teeth whitening products for professional and over-the-counter use. The company also offers River8, a prefab veneer that enables the dentist to find the right combination of teeth for a patient with minor reshaping. In addition, it provides GlamSmile veneers, which are ultra-thin claddings attached to the front of the patient’s teeth. Further, the company offers SmileMe Mirror, an integrated marketing concept for the dental practice that enables dentists to offer smile consultation in approximately 10 minutes; SmileSketch, a simulation software to make a sketch of what the patient could look like; and various Treatment Pages to explain the benefits of certain treatments, as well as Condor, an intra-oral 3D scanner. Additionally, it provides dental implant solutions and treatment concepts. The company sells its products through internal sales force and third party distributors. Remedent, Inc. was incorporated in 1986 and is headquartered in Ghent, Belgium.
Receive News & Ratings for Remedent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Remedent and related companies with MarketBeat.com's FREE daily email newsletter.